Amarin Corp Plc (AMRN)

[ziploc_1]

Nsleven...There was, in fact, a difference between the Hikma and Healthnet cases...Hikma relied on the often used, but implausible excuse, that they were unaware of any infringement...Healthnet was requesting authorized statements from Docs before agreeing to pay for Vascepa Rx's...which they then paid for, even though the Docs clearly stated on the authorizations that Rx's were for the treatment of CVD, clearly in infringment on Amarin's CVD patents....so Hickma could not use the 'I didn't know' excuse.